High-dose chemo-radiotherapy followed by autologous Philadelphia chromosome-negative blood progenitor cell transplantation in patients with chronic myelogenous leukemia

Bone Marrow Transplantation

Volumn 17, Issue 2, 1996, Pages 201-205

  Carella, A M ^a,c   Chimirri, F ^a   Podesta M ^a   Pitto, A ^a   Piaggio, G ^a   Dejana, A ^a   Lerma, E ^a   Pollicardo, N ^a   Vassallo, F ^a   Soracco, M ^a   Benvenuto, F ^a   Valbonesi, M ^a   Carlier, P ^a   Vimercati, R ^a   Prencipe, E ^b   Gatti, A M ^b   Ferrara, R A ^a   Incagliato, M ^a   Florio, G ^a   Frassoni, F ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b DIMI   (Italy)

^c Hematology and ABMT Unit   (Italy)

Author keywords

CML; High dose therapy; Ph negative progenitor

Indexed keywords

ALPHA INTERFERON; ANTIBIOTIC AGENT; ANTIFUNGAL AGENT; ANTINEOPLASTIC AGENT; BUSULFAN; CYCLOPHOSPHAMIDE; CYTARABINE; ETOPOSIDE; HLA ANTIGEN; IDARUBICIN; INTERLEUKIN 2; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ADULT; APLASIA; ARTICLE; AUTOGRAFT; BLAST TRANSFORMATION; BONE MARROW SUPPRESSION; CHRONIC MYELOID LEUKEMIA; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG FATALITY; FEMALE; FEVER; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; PHILADELPHIA 1 CHROMOSOME; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL; THROMBOCYTOPENIA; WHOLE BODY RADIATION;

ADULT; ANEMIA, APLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOLOGICAL RESPONSE MODIFIERS; BLAST CRISIS; BONE MARROW; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; IFOSFAMIDE; INTERFERON-ALPHA; LEUKAPHERESIS; LEUKEMIA, MYELOID, CHRONIC-PHASE; LEUKEMIA, MYELOID, PHILADELPHIA-POSITIVE; MALE; MIDDLE AGED; NEOPLASM CIRCULATING CELLS; NEOPLASM, RESIDUAL; PHILADELPHIA CHROMOSOME; SURVIVAL ANALYSIS; THROMBOCYTOPENIA; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME; WHOLE-BODY IRRADIATION;

EID: 13344276573     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Goldman JM, Gale RP, Horowitz M et al. Bone marrow transplantation for chronic myelogenous leukemia in chronic phase. Increased risk for relapse associated with T-cell depletion. Ann Intern Med 1988; 108: 806-814.
2. Reiffers J, Goldman J, Meloni G et al. Autologous transplantation in chronic myelogenous leukemia: European results. Bone Marrow Transplant 1994, 14 (Suppl. 3): 51-54.
3. McGlave PB, DeFabritüs P, Deisseroth A et al. Autologous transplant therapy for chronic myelogenous leukemia prolongs survival: results from eight transplant groups. Lancet 1994, 343; 1486-1491.
4. Carella AM, Podestà M, Frassoni F et al. Collection of 'normal' blood repopulating cells during early hemopoietic recovery after intensive conventional chemotherapy in CML. Bone Marrow Transplant 1993; 12: 267-271.
5. Kantarjian H, Talpaz M, Herster J et al. Collection of peripheral blood diploid cells from chronic myelogenous leukemia patients early in the recovery phase from myelosuppression induced by intensive chemotherapy. Blood 1994; 84 (Suppl. 1) 1514 (abstr.).
6. Chalmers EA, Franklin EM, Kelsey S et al. Mobilization of Ph-negative peripheral blood stem cells in CML with idarubicin and cytarabine. Bone Marrow Transplant 1994; 14 (Suppl. 3): 38-41.
7. Durrant S, Taylor K, Moore D et al. Bone marrow transplantation following intensive chemotherapy with filgrastim support and progenitor cell collection in advanced chronic myeloid leukemia (CML). Bone Marrow Transplant 1995; 15 (Suppl. 2) 101 (abstr.).
8. Gewirtz AM. Treatment of chronic myelogenous leukemia with c-myb antisense oligodeoxynucleotides. Bone Marrow Transplant 1994; 14 (Suppl. 3): 57-61.
9. Carlo-Stella C, Mangoni L, Piovani G et al. Identification of Philadelphia-negative granulocyte-macrophage colony-forming units generated by stroma-adherent cells from chronic myelogenous leukemia patients. Blood 1994; 83: 1373-1380.
10. Simonsson B, Oberg G, Killander A et al. Intensive treatment in order to minimize the Ph-positive clone in chronic myelogenous leukemia. Bone Marrow Transplant 1994; 14 (Suppl. 3): 55-56.
11. Barnett MJ, Eaves CJ, Phillips GL et al. Autografting in chronic myeloid leukemia with cultured marrow. Leukemia 1992; 6 (Suppl. 4): 118-119.
12. Carella AM, Frassoni F, Podestà M et al. Idarubicin containing regimen and G-CSF are able to recruit a high rate of normal progenitor cells during early hemopoietic recovery in patients with CML. J Hematotherapy 1994; 3: 199-202.
13. Hatzold K, Karakassis D, JPh Laporte et al. Attempts at positive selection of 'normal' (Philadelphia chromosome negative) stem cells in patients with chronic myelocytic leukemia (CML). Bone Marrow Transplant 1994; 14 (Suppl. 3): 79.
14. Sureda A, Burnet S, Amill B et al. Peripheral blood stem cell mobilization in patients with chronic myeloid leukemia. Bone Marrow Transplant 1995: 15 (Suppl. 2): 104 (abstr.).
15. Bouquè C. Petit J. Sarrà J et al. Mobilization of circulating stem cells. Results with the ICE treatment in Ph-positive chronic myeloid leukemia. Bone Marrow Transplant 1995: 15 (Suppl. 2): 105 (abstr.).
16. Crotty GM, Judge G, DeArce M et al. Mobilization of peripheral blood progenitors from patients with chronic myeloid leukemia in first stable phase. Bone Marrow Transplant 1995; 15 (Suppl. 2) 106 (abstr.).